Skip to main content
Premium Trial:

Request an Annual Quote

Gentel Acquires Trademark from Eppendorf

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gentel Biosciences today said that it has acquired the SilverQuant trademark from Eppendorf, which it will apply to its protein array technology platform.

Madison, Wis.-based Gentel said the acquisition of the trademark complements its other initiatives to grow its market position as a provider of multiplexed proteomic tools.

In 2008, Gentel had acquired from Eppendorf the rights to array-based chromogenic detection technology that uses gold particle-enhanced silver crystal deposition for detection and quantification of arrays. Today, it said that the SilverQuant technology works with the Gentel Proteomics Multi-System, which integrates chromogenic scanning and analysis of arrays at a price comparable to a benchtop ELISA system.

"The SilverQuant name accurately describes our unique chromogenic detection technology as well as its application to protein quantitation," Gentel VP of Commercial Development Dan Clutter said in a statement. "Further, SilverQuant is a strong trademark that adds a valuable intangible asset to the company given its worldwide registration and existing prestige in the life sciences."

Financial terms of the trademark acquisition were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.